A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system

Background: Apalutamide is a new drug class, which is approved to treat prostate cancer (PCa). The aim of our study was to assess the safety profiles of apalutamide in real-world through data mining of the United States Food and Drug Administration Adverse Event Reporting System (FAERS).Method: We i...

Полное описание

Библиографические подробности

Главные авторы:	Zhihong Fang, Zhiqiang Xu, Wei Zhu, Mingming Yu, Chunmei Ji
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2023-06-01
Серии:	Frontiers in Pharmacology
Предметы:	apalutamide FDA adverse event reporting system disproportionality analyses adverse event real-world
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1101861/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!